IV repletion is used in clinical practice as part of protocols for NAFLD, NASH, alcoholic liver disease, viral hepatitis B and C, heavy metal and environmental toxin exposure, mold toxicity protocols, and post-acetaminophen toxicity recovery
Adding GIP enhances fat metabolism and improves insulin sensitivity, which is why tirzepatide outperforms semaglutide on weight loss
J Neuroimmune Pharmacol
These findings align with NAD+ biology: when cellular NAD+ rises, the NAD+/NADH ratio shifts, favoring oxidative over reductive metabolism
Key Players: Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc & more
If they cannot or will not share COAs, look elsewhere